JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo

Among those waiting for results from clinical trials of JAK inhibitors is Lucky Meisenheimer, MD, a dermatologist in private practice in Orlando. These three disorders share an underlying impairment of the immune system and they all tend to be chronic conditions, he told Medscape Medical News.

“It’s always exciting when the possibility of new drugs with different mechanisms of action from current mainstay treatments show promise,” he added.

Be the first to comment

Leave a Reply

Your email address will not be published.